FINAL BILL REPORT
SSB 5546
C 10 L 22
Synopsis as Enacted
Brief Description: Concerning insulin affordability.
Sponsors: Senate Committee on Health & Long Term Care (originally sponsored by Senators Keiser, Van De Wege, Cleveland, Conway, Frockt, Hasegawa, Hunt, Lovick, Nguyen, Pedersen, Randall, Stanford and Wilson, C.).
Senate Committee on Health & Long Term Care
House Committee on Health Care & Wellness
Background:

In 2020, the Legislature directed health plans, beginning January 1, 2021, to limit an enrollee's out-of-pocket expenses for insulin to $100 for a 30-day supply.  The out-of-pocket limit is set to expire on January 1, 2023.
Summary:

Beginning January 1, 2023, health plans must cap the total amount an enrollee is required to pay for a covered insulin drug at an amount not to exceed $35 per 30-day supply.  This limit expires on January 1, 2024.
Votes on Final Passage:
Senate 48 1
House 85 10
Effective:

June 9, 2022

January 1, 2023 (Section 1)